nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CYP2D6—schizophrenia	0.233	0.583	CbGaD
Nilotinib—ABCB1—schizophrenia	0.166	0.417	CbGaD
Nilotinib—Ponatinib—CYP2D6—schizophrenia	0.00134	0.28	CrCbGaD
Nilotinib—CDC42BPB—endocrine gland—schizophrenia	0.0013	0.00559	CbGeAlD
Nilotinib—MAPK14—forebrain—schizophrenia	0.00129	0.00554	CbGeAlD
Nilotinib—EPHA4—telencephalon—schizophrenia	0.00129	0.00552	CbGeAlD
Nilotinib—EPHA8—central nervous system—schizophrenia	0.00127	0.00546	CbGeAlD
Nilotinib—CA3—telencephalon—schizophrenia	0.00127	0.00545	CbGeAlD
Nilotinib—LYN—blood—schizophrenia	0.00126	0.00538	CbGeAlD
Nilotinib—EPHA8—cerebellum—schizophrenia	0.00125	0.00534	CbGeAlD
Nilotinib—MAP4K1—blood—schizophrenia	0.00124	0.0053	CbGeAlD
Nilotinib—MAPK11—nervous system—schizophrenia	0.00123	0.00528	CbGeAlD
Nilotinib—CDC42BPB—nervous system—schizophrenia	0.00122	0.00523	CbGeAlD
Nilotinib—MAPK14—telencephalon—schizophrenia	0.00119	0.00509	CbGeAlD
Nilotinib—MAPK11—central nervous system—schizophrenia	0.00119	0.00508	CbGeAlD
Nilotinib—MAPK8—endocrine gland—schizophrenia	0.00118	0.00506	CbGeAlD
Nilotinib—EPHA6—endocrine gland—schizophrenia	0.00118	0.00506	CbGeAlD
Nilotinib—CDC42BPB—central nervous system—schizophrenia	0.00118	0.00504	CbGeAlD
Nilotinib—MAPK11—cerebellum—schizophrenia	0.00116	0.00496	CbGeAlD
Nilotinib—EPHA3—nervous system—schizophrenia	0.00116	0.00496	CbGeAlD
Nilotinib—CA14—telencephalon—schizophrenia	0.00116	0.00495	CbGeAlD
Nilotinib—CDC42BPB—cerebellum—schizophrenia	0.00115	0.00492	CbGeAlD
Nilotinib—CYP3A4—urine—schizophrenia	0.00114	0.00487	CbGeAlD
Nilotinib—BRAF—blood—schizophrenia	0.00113	0.00485	CbGeAlD
Nilotinib—EPHB4—telencephalon—schizophrenia	0.00113	0.00483	CbGeAlD
Nilotinib—EPHB6—forebrain—schizophrenia	0.00112	0.0048	CbGeAlD
Nilotinib—CYP2D6—urine—schizophrenia	0.00112	0.00479	CbGeAlD
Nilotinib—BRAF—midbrain—schizophrenia	0.00112	0.00478	CbGeAlD
Nilotinib—EPHA3—central nervous system—schizophrenia	0.00111	0.00478	CbGeAlD
Nilotinib—MAPK8—nervous system—schizophrenia	0.0011	0.00473	CbGeAlD
Nilotinib—EPHA6—nervous system—schizophrenia	0.0011	0.00473	CbGeAlD
Nilotinib—LYN—endocrine gland—schizophrenia	0.00109	0.00467	CbGeAlD
Nilotinib—TEK—telencephalon—schizophrenia	0.00108	0.00462	CbGeAlD
Nilotinib—EPHA4—gonad—schizophrenia	0.00108	0.00461	CbGeAlD
Nilotinib—Imatinib—CYP1A2—schizophrenia	0.00107	0.224	CrCbGaD
Nilotinib—MAPK8—central nervous system—schizophrenia	0.00106	0.00456	CbGeAlD
Nilotinib—EPHA6—central nervous system—schizophrenia	0.00106	0.00456	CbGeAlD
Nilotinib—PDGFRA—forebrain—schizophrenia	0.00106	0.00455	CbGeAlD
Nilotinib—EPHB2—brain—schizophrenia	0.00106	0.00452	CbGeAlD
Nilotinib—MAPK8—cerebellum—schizophrenia	0.00104	0.00445	CbGeAlD
Nilotinib—HCK—blood—schizophrenia	0.00103	0.00442	CbGeAlD
Nilotinib—EPHB6—telencephalon—schizophrenia	0.00103	0.00441	CbGeAlD
Nilotinib—ABL2—blood—schizophrenia	0.00102	0.00439	CbGeAlD
Nilotinib—LYN—nervous system—schizophrenia	0.00102	0.00437	CbGeAlD
Nilotinib—HCK—midbrain—schizophrenia	0.00102	0.00436	CbGeAlD
Nilotinib—EPHA8—brain—schizophrenia	0.00101	0.00434	CbGeAlD
Nilotinib—CA7—midbrain—schizophrenia	0.000996	0.00427	CbGeAlD
Nilotinib—LYN—central nervous system—schizophrenia	0.000981	0.0042	CbGeAlD
Nilotinib—CA12—forebrain—schizophrenia	0.00098	0.0042	CbGeAlD
Nilotinib—PDGFRA—telencephalon—schizophrenia	0.000976	0.00418	CbGeAlD
Nilotinib—Ponatinib—ABCB1—schizophrenia	0.000958	0.2	CrCbGaD
Nilotinib—TIE1—nervous system—schizophrenia	0.000957	0.0041	CbGeAlD
Nilotinib—MAPK11—brain—schizophrenia	0.000941	0.00403	CbGeAlD
Nilotinib—EPHA4—blood—schizophrenia	0.000937	0.00401	CbGeAlD
Nilotinib—CSF1R—forebrain—schizophrenia	0.000935	0.00401	CbGeAlD
Nilotinib—CDC42BPB—brain—schizophrenia	0.000933	0.004	CbGeAlD
Nilotinib—TIE1—central nervous system—schizophrenia	0.000922	0.00395	CbGeAlD
Nilotinib—CA2—blood plasma—schizophrenia	0.000918	0.00394	CbGeAlD
Nilotinib—EPHB3—nervous system—schizophrenia	0.000911	0.0039	CbGeAlD
Nilotinib—CA12—telencephalon—schizophrenia	0.000901	0.00386	CbGeAlD
Nilotinib—TIE1—cerebellum—schizophrenia	0.000901	0.00386	CbGeAlD
Nilotinib—HCK—endocrine gland—schizophrenia	0.000894	0.00383	CbGeAlD
Nilotinib—EPHA3—brain—schizophrenia	0.000885	0.00379	CbGeAlD
Nilotinib—MAP2K5—telencephalon—schizophrenia	0.000881	0.00377	CbGeAlD
Nilotinib—EPHB3—central nervous system—schizophrenia	0.000877	0.00376	CbGeAlD
Nilotinib—CYP2C8—blood plasma—schizophrenia	0.000875	0.00375	CbGeAlD
Nilotinib—MAPK14—blood—schizophrenia	0.000864	0.0037	CbGeAlD
Nilotinib—BRAF—cerebellum—schizophrenia	0.000864	0.0037	CbGeAlD
Nilotinib—LCK—blood—schizophrenia	0.00086	0.00369	CbGeAlD
Nilotinib—FGR—blood—schizophrenia	0.00086	0.00369	CbGeAlD
Nilotinib—CSF1R—telencephalon—schizophrenia	0.00086	0.00368	CbGeAlD
Nilotinib—EPHB3—cerebellum—schizophrenia	0.000857	0.00367	CbGeAlD
Nilotinib—MAPK8—brain—schizophrenia	0.000844	0.00362	CbGeAlD
Nilotinib—EPHA6—brain—schizophrenia	0.000844	0.00362	CbGeAlD
Nilotinib—HCK—nervous system—schizophrenia	0.000837	0.00359	CbGeAlD
Nilotinib—CA14—midbrain—schizophrenia	0.00083	0.00356	CbGeAlD
Nilotinib—Imatinib—CYP2D6—schizophrenia	0.000826	0.173	CrCbGaD
Nilotinib—EPHB4—blood—schizophrenia	0.000819	0.00351	CbGeAlD
Nilotinib—PDGFRA—gonad—schizophrenia	0.000815	0.00349	CbGeAlD
Nilotinib—EPHA4—endocrine gland—schizophrenia	0.000813	0.00348	CbGeAlD
Nilotinib—EPHB4—midbrain—schizophrenia	0.000809	0.00347	CbGeAlD
Nilotinib—HCK—central nervous system—schizophrenia	0.000806	0.00345	CbGeAlD
Nilotinib—EPHA2—blood—schizophrenia	0.000803	0.00344	CbGeAlD
Nilotinib—CA3—endocrine gland—schizophrenia	0.000803	0.00344	CbGeAlD
Nilotinib—CYP2B6—blood plasma—schizophrenia	0.000785	0.00336	CbGeAlD
Nilotinib—TEK—blood—schizophrenia	0.000784	0.00336	CbGeAlD
Nilotinib—ABL2—cerebellum—schizophrenia	0.000782	0.00335	CbGeAlD
Nilotinib—KIT—telencephalon—schizophrenia	0.00078	0.00334	CbGeAlD
Nilotinib—LYN—brain—schizophrenia	0.000779	0.00334	CbGeAlD
Nilotinib—CYP2C9—blood plasma—schizophrenia	0.000777	0.00333	CbGeAlD
Nilotinib—CA1—forebrain—schizophrenia	0.000776	0.00333	CbGeAlD
Nilotinib—TEK—midbrain—schizophrenia	0.000774	0.00332	CbGeAlD
Nilotinib—CA7—cerebellum—schizophrenia	0.000771	0.0033	CbGeAlD
Nilotinib—CA9—endocrine gland—schizophrenia	0.000768	0.00329	CbGeAlD
Nilotinib—MAP4K1—brain—schizophrenia	0.000767	0.00329	CbGeAlD
Nilotinib—PDGFRB—telencephalon—schizophrenia	0.000762	0.00327	CbGeAlD
Nilotinib—EPHA4—nervous system—schizophrenia	0.000761	0.00326	CbGeAlD
Nilotinib—CA3—nervous system—schizophrenia	0.000751	0.00322	CbGeAlD
Nilotinib—MAPK14—endocrine gland—schizophrenia	0.000749	0.00321	CbGeAlD
Nilotinib—EPHB6—blood—schizophrenia	0.000749	0.00321	CbGeAlD
Nilotinib—FGR—endocrine gland—schizophrenia	0.000746	0.0032	CbGeAlD
Nilotinib—EPHB6—midbrain—schizophrenia	0.00074	0.00317	CbGeAlD
Nilotinib—EPHA4—central nervous system—schizophrenia	0.000732	0.00314	CbGeAlD
Nilotinib—TIE1—brain—schizophrenia	0.000732	0.00314	CbGeAlD
Nilotinib—CA3—central nervous system—schizophrenia	0.000723	0.0031	CbGeAlD
Nilotinib—CSF1R—gonad—schizophrenia	0.000717	0.00307	CbGeAlD
Nilotinib—EPHA4—cerebellum—schizophrenia	0.000716	0.00307	CbGeAlD
Nilotinib—CA1—telencephalon—schizophrenia	0.000714	0.00306	CbGeAlD
Nilotinib—EPHB4—endocrine gland—schizophrenia	0.00071	0.00304	CbGeAlD
Nilotinib—PDGFRA—blood—schizophrenia	0.00071	0.00304	CbGeAlD
Nilotinib—BRAF—brain—schizophrenia	0.000702	0.00301	CbGeAlD
Nilotinib—MAPK14—nervous system—schizophrenia	0.000701	0.00301	CbGeAlD
Nilotinib—FGR—nervous system—schizophrenia	0.000698	0.00299	CbGeAlD
Nilotinib—EPHA2—endocrine gland—schizophrenia	0.000697	0.00299	CbGeAlD
Nilotinib—EPHB3—brain—schizophrenia	0.000696	0.00298	CbGeAlD
Nilotinib—TEK—endocrine gland—schizophrenia	0.00068	0.00291	CbGeAlD
Nilotinib—ABL1—telencephalon—schizophrenia	0.000679	0.00291	CbGeAlD
Nilotinib—UGT1A1—blood—schizophrenia	0.000677	0.0029	CbGeAlD
Nilotinib—CA9—cerebellum—schizophrenia	0.000677	0.0029	CbGeAlD
Nilotinib—MAPK14—central nervous system—schizophrenia	0.000675	0.00289	CbGeAlD
Nilotinib—FGR—central nervous system—schizophrenia	0.000672	0.00288	CbGeAlD
Nilotinib—MAPK14—cerebellum—schizophrenia	0.00066	0.00283	CbGeAlD
Nilotinib—EPHA2—nervous system—schizophrenia	0.000652	0.00279	CbGeAlD
Nilotinib—KIT—gonad—schizophrenia	0.000651	0.00279	CbGeAlD
Nilotinib—CA14—cerebellum—schizophrenia	0.000642	0.00275	CbGeAlD
Nilotinib—MAP2K5—blood—schizophrenia	0.00064	0.00274	CbGeAlD
Nilotinib—HCK—brain—schizophrenia	0.00064	0.00274	CbGeAlD
Nilotinib—PDGFRB—gonad—schizophrenia	0.000636	0.00273	CbGeAlD
Nilotinib—TEK—nervous system—schizophrenia	0.000636	0.00273	CbGeAlD
Nilotinib—ABL2—brain—schizophrenia	0.000636	0.00272	CbGeAlD
Nilotinib—MAP2K5—midbrain—schizophrenia	0.000632	0.00271	CbGeAlD
Nilotinib—EPHA2—central nervous system—schizophrenia	0.000628	0.00269	CbGeAlD
Nilotinib—CA7—brain—schizophrenia	0.000626	0.00268	CbGeAlD
Nilotinib—EPHB4—cerebellum—schizophrenia	0.000626	0.00268	CbGeAlD
Nilotinib—CSF1R—blood—schizophrenia	0.000625	0.00268	CbGeAlD
Nilotinib—CSF1R—midbrain—schizophrenia	0.000617	0.00265	CbGeAlD
Nilotinib—PDGFRA—endocrine gland—schizophrenia	0.000616	0.00264	CbGeAlD
Nilotinib—TEK—central nervous system—schizophrenia	0.000613	0.00262	CbGeAlD
Nilotinib—EPHB6—nervous system—schizophrenia	0.000608	0.00261	CbGeAlD
Nilotinib—CA4—forebrain—schizophrenia	0.000607	0.0026	CbGeAlD
Nilotinib—TEK—cerebellum—schizophrenia	0.000599	0.00257	CbGeAlD
Nilotinib—CYP3A4—blood plasma—schizophrenia	0.000593	0.00254	CbGeAlD
Nilotinib—Imatinib—ABCB1—schizophrenia	0.00059	0.123	CrCbGaD
Nilotinib—UGT1A1—endocrine gland—schizophrenia	0.000587	0.00252	CbGeAlD
Nilotinib—EPHB6—central nervous system—schizophrenia	0.000585	0.00251	CbGeAlD
Nilotinib—CYP2D6—blood plasma—schizophrenia	0.000583	0.0025	CbGeAlD
Nilotinib—EPHA4—brain—schizophrenia	0.000581	0.00249	CbGeAlD
Nilotinib—PDGFRA—nervous system—schizophrenia	0.000576	0.00247	CbGeAlD
Nilotinib—CA3—brain—schizophrenia	0.000574	0.00246	CbGeAlD
Nilotinib—EPHB6—cerebellum—schizophrenia	0.000572	0.00245	CbGeAlD
Nilotinib—CA12—endocrine gland—schizophrenia	0.000568	0.00244	CbGeAlD
Nilotinib—KIT—blood—schizophrenia	0.000568	0.00243	CbGeAlD
Nilotinib—ABL1—gonad—schizophrenia	0.000567	0.00243	CbGeAlD
Nilotinib—KIT—midbrain—schizophrenia	0.00056	0.0024	CbGeAlD
Nilotinib—CA4—telencephalon—schizophrenia	0.000558	0.00239	CbGeAlD
Nilotinib—MAP2K5—endocrine gland—schizophrenia	0.000556	0.00238	CbGeAlD
Nilotinib—PDGFRA—central nervous system—schizophrenia	0.000555	0.00238	CbGeAlD
Nilotinib—PDGFRB—blood—schizophrenia	0.000554	0.00238	CbGeAlD
Nilotinib—PDGFRB—midbrain—schizophrenia	0.000547	0.00235	CbGeAlD
Nilotinib—PDGFRA—cerebellum—schizophrenia	0.000542	0.00232	CbGeAlD
Nilotinib—CSF1R—endocrine gland—schizophrenia	0.000542	0.00232	CbGeAlD
Nilotinib—MAPK14—brain—schizophrenia	0.000536	0.0023	CbGeAlD
Nilotinib—FGR—brain—schizophrenia	0.000534	0.00229	CbGeAlD
Nilotinib—CA12—nervous system—schizophrenia	0.000532	0.00228	CbGeAlD
Nilotinib—CA14—brain—schizophrenia	0.000521	0.00223	CbGeAlD
Nilotinib—MAP2K5—nervous system—schizophrenia	0.00052	0.00223	CbGeAlD
Nilotinib—CA1—blood—schizophrenia	0.000519	0.00222	CbGeAlD
Nilotinib—CA12—central nervous system—schizophrenia	0.000512	0.00219	CbGeAlD
Nilotinib—EPHB4—brain—schizophrenia	0.000508	0.00218	CbGeAlD
Nilotinib—CSF1R—nervous system—schizophrenia	0.000507	0.00217	CbGeAlD
Nilotinib—CA2—forebrain—schizophrenia	0.000503	0.00216	CbGeAlD
Nilotinib—MAP2K5—central nervous system—schizophrenia	0.000501	0.00215	CbGeAlD
Nilotinib—EPHA2—brain—schizophrenia	0.000498	0.00214	CbGeAlD
Nilotinib—ABL1—blood—schizophrenia	0.000494	0.00212	CbGeAlD
Nilotinib—KIT—endocrine gland—schizophrenia	0.000492	0.00211	CbGeAlD
Nilotinib—MAP2K5—cerebellum—schizophrenia	0.000489	0.0021	CbGeAlD
Nilotinib—CSF1R—central nervous system—schizophrenia	0.000489	0.00209	CbGeAlD
Nilotinib—ABL1—midbrain—schizophrenia	0.000488	0.00209	CbGeAlD
Nilotinib—TEK—brain—schizophrenia	0.000486	0.00208	CbGeAlD
Nilotinib—PDGFRB—endocrine gland—schizophrenia	0.000481	0.00206	CbGeAlD
Nilotinib—CSF1R—cerebellum—schizophrenia	0.000478	0.00205	CbGeAlD
Nilotinib—EPHB6—brain—schizophrenia	0.000465	0.00199	CbGeAlD
Nilotinib—CA2—telencephalon—schizophrenia	0.000463	0.00198	CbGeAlD
Nilotinib—KIT—nervous system—schizophrenia	0.000461	0.00197	CbGeAlD
Nilotinib—CA1—endocrine gland—schizophrenia	0.00045	0.00193	CbGeAlD
Nilotinib—PDGFRB—nervous system—schizophrenia	0.00045	0.00193	CbGeAlD
Nilotinib—KIT—central nervous system—schizophrenia	0.000444	0.0019	CbGeAlD
Nilotinib—PDGFRA—brain—schizophrenia	0.000441	0.00189	CbGeAlD
Nilotinib—KIT—cerebellum—schizophrenia	0.000434	0.00186	CbGeAlD
Nilotinib—PDGFRB—central nervous system—schizophrenia	0.000433	0.00186	CbGeAlD
Nilotinib—ABL1—endocrine gland—schizophrenia	0.000429	0.00184	CbGeAlD
Nilotinib—ABCG2—telencephalon—schizophrenia	0.000428	0.00184	CbGeAlD
Nilotinib—PDGFRB—cerebellum—schizophrenia	0.000423	0.00181	CbGeAlD
Nilotinib—CA1—nervous system—schizophrenia	0.000421	0.00181	CbGeAlD
Nilotinib—ABCB1—blood plasma—schizophrenia	0.000419	0.0018	CbGeAlD
Nilotinib—CA12—brain—schizophrenia	0.000407	0.00174	CbGeAlD
Nilotinib—CA4—blood—schizophrenia	0.000406	0.00174	CbGeAlD
Nilotinib—CA1—central nervous system—schizophrenia	0.000406	0.00174	CbGeAlD
Nilotinib—ABL1—nervous system—schizophrenia	0.000401	0.00172	CbGeAlD
Nilotinib—CA4—midbrain—schizophrenia	0.000401	0.00172	CbGeAlD
Nilotinib—MAP2K5—brain—schizophrenia	0.000397	0.0017	CbGeAlD
Nilotinib—CSF1R—brain—schizophrenia	0.000388	0.00166	CbGeAlD
Nilotinib—ABL1—central nervous system—schizophrenia	0.000386	0.00165	CbGeAlD
Nilotinib—ABL1—cerebellum—schizophrenia	0.000377	0.00162	CbGeAlD
Nilotinib—KIT—brain—schizophrenia	0.000352	0.00151	CbGeAlD
Nilotinib—CA4—endocrine gland—schizophrenia	0.000352	0.00151	CbGeAlD
Nilotinib—PDGFRB—brain—schizophrenia	0.000344	0.00147	CbGeAlD
Nilotinib—CA2—blood—schizophrenia	0.000336	0.00144	CbGeAlD
Nilotinib—CA2—midbrain—schizophrenia	0.000332	0.00142	CbGeAlD
Nilotinib—CYP2B6—gonad—schizophrenia	0.00033	0.00141	CbGeAlD
Nilotinib—CA4—nervous system—schizophrenia	0.000329	0.00141	CbGeAlD
Nilotinib—CA1—brain—schizophrenia	0.000322	0.00138	CbGeAlD
Nilotinib—CYP2C8—blood—schizophrenia	0.00032	0.00137	CbGeAlD
Nilotinib—CYP2D6—forebrain—schizophrenia	0.000319	0.00137	CbGeAlD
Nilotinib—CA4—central nervous system—schizophrenia	0.000317	0.00136	CbGeAlD
Nilotinib—ABCG2—blood—schizophrenia	0.000312	0.00134	CbGeAlD
Nilotinib—CA4—cerebellum—schizophrenia	0.00031	0.00133	CbGeAlD
Nilotinib—ABCG2—midbrain—schizophrenia	0.000308	0.00132	CbGeAlD
Nilotinib—ABL1—brain—schizophrenia	0.000307	0.00131	CbGeAlD
Nilotinib—CYP2D6—telencephalon—schizophrenia	0.000294	0.00126	CbGeAlD
Nilotinib—CA2—endocrine gland—schizophrenia	0.000292	0.00125	CbGeAlD
Nilotinib—CYP2B6—blood—schizophrenia	0.000287	0.00123	CbGeAlD
Nilotinib—CYP2C9—blood—schizophrenia	0.000285	0.00122	CbGeAlD
Nilotinib—CYP2C8—endocrine gland—schizophrenia	0.000278	0.00119	CbGeAlD
Nilotinib—CA2—nervous system—schizophrenia	0.000273	0.00117	CbGeAlD
Nilotinib—CA2—central nervous system—schizophrenia	0.000263	0.00113	CbGeAlD
Nilotinib—CA2—cerebellum—schizophrenia	0.000257	0.0011	CbGeAlD
Nilotinib—CA4—brain—schizophrenia	0.000252	0.00108	CbGeAlD
Nilotinib—CYP2B6—endocrine gland—schizophrenia	0.000249	0.00107	CbGeAlD
Nilotinib—CYP2C9—endocrine gland—schizophrenia	0.000247	0.00106	CbGeAlD
Nilotinib—ABCG2—cerebellum—schizophrenia	0.000238	0.00102	CbGeAlD
Nilotinib—CYP2B6—nervous system—schizophrenia	0.000233	0.001	CbGeAlD
Nilotinib—ABCB1—forebrain—schizophrenia	0.00023	0.000985	CbGeAlD
Nilotinib—CYP2B6—central nervous system—schizophrenia	0.000225	0.000963	CbGeAlD
Nilotinib—CYP3A4—blood—schizophrenia	0.000217	0.00093	CbGeAlD
Nilotinib—CYP2D6—blood—schizophrenia	0.000214	0.000915	CbGeAlD
Nilotinib—ABCB1—telencephalon—schizophrenia	0.000211	0.000905	CbGeAlD
Nilotinib—CA2—brain—schizophrenia	0.000209	0.000895	CbGeAlD
Nilotinib—CYP2C8—brain—schizophrenia	0.000199	0.000852	CbGeAlD
Nilotinib—ABCG2—brain—schizophrenia	0.000193	0.000829	CbGeAlD
Nilotinib—CYP3A4—endocrine gland—schizophrenia	0.000188	0.000807	CbGeAlD
Nilotinib—CYP2D6—endocrine gland—schizophrenia	0.000185	0.000794	CbGeAlD
Nilotinib—CYP2B6—brain—schizophrenia	0.000178	0.000764	CbGeAlD
Nilotinib—ABCB1—gonad—schizophrenia	0.000176	0.000756	CbGeAlD
Nilotinib—CYP3A4—nervous system—schizophrenia	0.000176	0.000755	CbGeAlD
Nilotinib—CYP2D6—nervous system—schizophrenia	0.000173	0.000743	CbGeAlD
Nilotinib—CYP3A4—central nervous system—schizophrenia	0.00017	0.000727	CbGeAlD
Nilotinib—CYP2D6—central nervous system—schizophrenia	0.000167	0.000715	CbGeAlD
Nilotinib—CYP2D6—cerebellum—schizophrenia	0.000163	0.000699	CbGeAlD
Nilotinib—ABCB1—blood—schizophrenia	0.000154	0.000658	CbGeAlD
Nilotinib—ABCB1—midbrain—schizophrenia	0.000152	0.00065	CbGeAlD
Nilotinib—ABCB1—endocrine gland—schizophrenia	0.000133	0.000571	CbGeAlD
Nilotinib—CYP2D6—brain—schizophrenia	0.000133	0.000568	CbGeAlD
Nilotinib—ABCB1—nervous system—schizophrenia	0.000125	0.000535	CbGeAlD
Nilotinib—ABCB1—central nervous system—schizophrenia	0.00012	0.000515	CbGeAlD
Nilotinib—ABCB1—cerebellum—schizophrenia	0.000117	0.000503	CbGeAlD
Nilotinib—ABCB1—brain—schizophrenia	9.53e-05	0.000409	CbGeAlD
Nilotinib—KIT—Innate Immune System—AKT1—schizophrenia	5.7e-06	1.57e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—FOS—schizophrenia	5.68e-06	1.57e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GAPDH—schizophrenia	5.67e-06	1.56e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CLOCK—schizophrenia	5.67e-06	1.56e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—TH—schizophrenia	5.67e-06	1.56e-05	CbGpPWpGaD
Nilotinib—CA7—Metabolism—AKT1—schizophrenia	5.65e-06	1.56e-05	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	5.64e-06	1.56e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—YWHAZ—schizophrenia	5.64e-06	1.56e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—ESR1—schizophrenia	5.64e-06	1.55e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CLOCK—schizophrenia	5.62e-06	1.55e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	5.61e-06	1.55e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR2A—schizophrenia	5.6e-06	1.55e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—EP300—schizophrenia	5.58e-06	1.54e-05	CbGpPWpGaD
Nilotinib—CA9—Metabolism—EP300—schizophrenia	5.58e-06	1.54e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	5.54e-06	1.53e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—TPH2—schizophrenia	5.53e-06	1.52e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CACNB2—schizophrenia	5.53e-06	1.52e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ERBB4—schizophrenia	5.52e-06	1.52e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—ERBB3—schizophrenia	5.52e-06	1.52e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—EP300—schizophrenia	5.5e-06	1.52e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—TPH2—schizophrenia	5.48e-06	1.51e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CACNB2—schizophrenia	5.48e-06	1.51e-05	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—AKT1—schizophrenia	5.48e-06	1.51e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—DPYD—schizophrenia	5.44e-06	1.5e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—GSK3B—schizophrenia	5.4e-06	1.49e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—AKT1—schizophrenia	5.4e-06	1.49e-05	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—AKT1—schizophrenia	5.39e-06	1.49e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—DPYD—schizophrenia	5.39e-06	1.49e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—SNAP25—schizophrenia	5.38e-06	1.48e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP2D6—schizophrenia	5.38e-06	1.48e-05	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—AKT1—schizophrenia	5.37e-06	1.48e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CACNA1C—schizophrenia	5.36e-06	1.48e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP26B1—schizophrenia	5.35e-06	1.48e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—APOE—schizophrenia	5.32e-06	1.47e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MTHFR—schizophrenia	5.31e-06	1.47e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR2A—schizophrenia	5.31e-06	1.46e-05	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—AKT1—schizophrenia	5.29e-06	1.46e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—GSK3B—schizophrenia	5.28e-06	1.46e-05	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—AKT1—schizophrenia	5.27e-06	1.45e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—APOA1—schizophrenia	5.26e-06	1.45e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL1B—schizophrenia	5.25e-06	1.45e-05	CbGpPWpGaD
Nilotinib—CA12—Metabolism—AKT1—schizophrenia	5.23e-06	1.44e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PIK3C2A—schizophrenia	5.23e-06	1.44e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—APOE—schizophrenia	5.21e-06	1.44e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—EP300—schizophrenia	5.2e-06	1.44e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PLA2G4A—schizophrenia	5.19e-06	1.43e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—AKT1—schizophrenia	5.19e-06	1.43e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—APOA1—schizophrenia	5.15e-06	1.42e-05	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TP53—schizophrenia	5.14e-06	1.42e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL1B—schizophrenia	5.14e-06	1.42e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—GSK3B—schizophrenia	5.11e-06	1.41e-05	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—AKT1—schizophrenia	5.11e-06	1.41e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL1B—schizophrenia	5.11e-06	1.41e-05	CbGpPWpGaD
Nilotinib—HCK—Immune System—AKT1—schizophrenia	5.1e-06	1.41e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NRG1—schizophrenia	5.09e-06	1.4e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—ESR1—schizophrenia	5.08e-06	1.4e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—EP300—schizophrenia	5.08e-06	1.4e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CACNA1C—schizophrenia	5.05e-06	1.39e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MEF2C—schizophrenia	5.05e-06	1.39e-05	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—AKT1—schizophrenia	5.02e-06	1.38e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CACNA1C—schizophrenia	5.01e-06	1.38e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—ESR1—schizophrenia	4.97e-06	1.37e-05	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	4.95e-06	1.37e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—EP300—schizophrenia	4.95e-06	1.36e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—APOE—schizophrenia	4.95e-06	1.36e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—APOE—schizophrenia	4.94e-06	1.36e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PIK3C2A—schizophrenia	4.93e-06	1.36e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—APOA1—schizophrenia	4.89e-06	1.35e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PIK3C2A—schizophrenia	4.88e-06	1.35e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—APOA1—schizophrenia	4.88e-06	1.35e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—YWHAZ—schizophrenia	4.88e-06	1.35e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL1B—schizophrenia	4.87e-06	1.34e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP1A2—schizophrenia	4.87e-06	1.34e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—AKT1—schizophrenia	4.86e-06	1.34e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—COMT—schizophrenia	4.82e-06	1.33e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—EP300—schizophrenia	4.81e-06	1.33e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—TH—schizophrenia	4.8e-06	1.32e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GSTP1—schizophrenia	4.79e-06	1.32e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MAOA—schizophrenia	4.78e-06	1.32e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ERBB3—schizophrenia	4.77e-06	1.32e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TPH1—schizophrenia	4.77e-06	1.31e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GCLM—schizophrenia	4.77e-06	1.31e-05	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—AKT1—schizophrenia	4.76e-06	1.31e-05	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—AKT1—schizophrenia	4.74e-06	1.31e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—ESR1—schizophrenia	4.71e-06	1.3e-05	CbGpPWpGaD
Nilotinib—HCK—Disease—AKT1—schizophrenia	4.71e-06	1.3e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—EP300—schizophrenia	4.7e-06	1.3e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—EP300—schizophrenia	4.69e-06	1.29e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP2D6—schizophrenia	4.69e-06	1.29e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SNAP25—schizophrenia	4.69e-06	1.29e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—AKT1—schizophrenia	4.67e-06	1.29e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—AKT1—schizophrenia	4.62e-06	1.28e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—AKT1—schizophrenia	4.62e-06	1.28e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—AKT1—schizophrenia	4.61e-06	1.27e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—GSK3B—schizophrenia	4.61e-06	1.27e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2A—schizophrenia	4.59e-06	1.27e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—EP300—schizophrenia	4.59e-06	1.27e-05	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—AKT1—schizophrenia	4.57e-06	1.26e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—EP300—schizophrenia	4.57e-06	1.26e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ABCB1—schizophrenia	4.54e-06	1.25e-05	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—AKT1—schizophrenia	4.52e-06	1.25e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—GSK3B—schizophrenia	4.51e-06	1.24e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PRKD1—schizophrenia	4.48e-06	1.24e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SNAP25—schizophrenia	4.42e-06	1.22e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PLA2G4A—schizophrenia	4.41e-06	1.22e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GSTM1—schizophrenia	4.41e-06	1.22e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SNAP25—schizophrenia	4.38e-06	1.21e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP2D6—schizophrenia	4.38e-06	1.21e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—EP300—schizophrenia	4.35e-06	1.2e-05	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—AKT1—schizophrenia	4.34e-06	1.2e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—EP300—schizophrenia	4.33e-06	1.19e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—GSK3B—schizophrenia	4.28e-06	1.18e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—APOE—schizophrenia	4.27e-06	1.18e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP1A2—schizophrenia	4.24e-06	1.17e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—APOA1—schizophrenia	4.22e-06	1.16e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1B—schizophrenia	4.21e-06	1.16e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—TH—schizophrenia	4.18e-06	1.15e-05	CbGpPWpGaD
Nilotinib—CA4—Metabolism—AKT1—schizophrenia	4.17e-06	1.15e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—COMT—schizophrenia	4.08e-06	1.12e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ESR1—schizophrenia	4.08e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTP1—schizophrenia	4.06e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MAOA—schizophrenia	4.05e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CA2—Metabolism—AKT1—schizophrenia	4e-06	1.1e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP1A2—schizophrenia	4e-06	1.1e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP1A2—schizophrenia	3.96e-06	1.09e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—EP300—schizophrenia	3.94e-06	1.09e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—TH—schizophrenia	3.94e-06	1.09e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.93e-06	1.08e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—EP300—schizophrenia	3.91e-06	1.08e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—TH—schizophrenia	3.9e-06	1.08e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—AKT1—schizophrenia	3.9e-06	1.08e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MTHFR—schizophrenia	3.89e-06	1.07e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ABCB1—schizophrenia	3.84e-06	1.06e-05	CbGpPWpGaD
Nilotinib—CA1—Metabolism—AKT1—schizophrenia	3.83e-06	1.06e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—EP300—schizophrenia	3.76e-06	1.04e-05	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—AKT1—schizophrenia	3.75e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GAPDH—schizophrenia	3.74e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTM1—schizophrenia	3.73e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PLA2G4A—schizophrenia	3.73e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CLOCK—schizophrenia	3.71e-06	1.02e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—GSK3B—schizophrenia	3.7e-06	1.02e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—AKT1—schizophrenia	3.68e-06	1.02e-05	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—AKT1—schizophrenia	3.66e-06	1.01e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—APOE—schizophrenia	3.63e-06	1e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TPH2—schizophrenia	3.61e-06	9.97e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CACNB2—schizophrenia	3.61e-06	9.97e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—APOA1—schizophrenia	3.58e-06	9.88e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DPYD—schizophrenia	3.55e-06	9.8e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—EP300—schizophrenia	3.55e-06	9.8e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—COMT—schizophrenia	3.55e-06	9.8e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TP53—schizophrenia	3.54e-06	9.77e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTP1—schizophrenia	3.54e-06	9.75e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MAOA—schizophrenia	3.53e-06	9.73e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—EP300—schizophrenia	3.47e-06	9.58e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—AKT1—schizophrenia	3.37e-06	9.29e-06	CbGpPWpGaD
Nilotinib—CA9—Metabolism—AKT1—schizophrenia	3.37e-06	9.29e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TP53—schizophrenia	3.37e-06	9.28e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—EP300—schizophrenia	3.36e-06	9.28e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—COMT—schizophrenia	3.35e-06	9.23e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTP1—schizophrenia	3.33e-06	9.19e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MAOA—schizophrenia	3.32e-06	9.17e-06	CbGpPWpGaD
Nilotinib—KIT—Immune System—AKT1—schizophrenia	3.32e-06	9.16e-06	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—EP300—schizophrenia	3.32e-06	9.16e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—COMT—schizophrenia	3.32e-06	9.15e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CACNA1C—schizophrenia	3.3e-06	9.11e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTP1—schizophrenia	3.3e-06	9.11e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MTHFR—schizophrenia	3.3e-06	9.09e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MAOA—schizophrenia	3.3e-06	9.09e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PLA2G4A—schizophrenia	3.25e-06	8.96e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTM1—schizophrenia	3.25e-06	8.96e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	3.22e-06	8.88e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.2e-06	8.82e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ABCB1—schizophrenia	3.15e-06	8.7e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—AKT1—schizophrenia	3.15e-06	8.67e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ABCB1—schizophrenia	3.13e-06	8.63e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—APOE—schizophrenia	3.07e-06	8.46e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—AKT1—schizophrenia	3.07e-06	8.46e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTM1—schizophrenia	3.06e-06	8.45e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PLA2G4A—schizophrenia	3.06e-06	8.45e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PLA2G4A—schizophrenia	3.04e-06	8.37e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTM1—schizophrenia	3.04e-06	8.37e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—APOA1—schizophrenia	3.03e-06	8.37e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—EP300—schizophrenia	3.03e-06	8.36e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—AKT1—schizophrenia	2.99e-06	8.25e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—EP300—schizophrenia	2.97e-06	8.19e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—AKT1—schizophrenia	2.9e-06	8.01e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP2D6—schizophrenia	2.89e-06	7.97e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SNAP25—schizophrenia	2.89e-06	7.97e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MTHFR—schizophrenia	2.87e-06	7.92e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—AKT1—schizophrenia	2.84e-06	7.84e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—AKT1—schizophrenia	2.83e-06	7.81e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TP53—schizophrenia	2.82e-06	7.78e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—EP300—schizophrenia	2.82e-06	7.77e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—EP300—schizophrenia	2.81e-06	7.76e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TP53—schizophrenia	2.79e-06	7.71e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—AKT1—schizophrenia	2.77e-06	7.65e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—AKT1—schizophrenia	2.76e-06	7.62e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MTHFR—schizophrenia	2.71e-06	7.46e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MTHFR—schizophrenia	2.68e-06	7.4e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—APOE—schizophrenia	2.67e-06	7.37e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—APOA1—schizophrenia	2.64e-06	7.29e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—AKT1—schizophrenia	2.63e-06	7.25e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—AKT1—schizophrenia	2.62e-06	7.21e-06	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—AKT1—schizophrenia	2.62e-06	7.21e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP1A2—schizophrenia	2.61e-06	7.2e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TH—schizophrenia	2.57e-06	7.1e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TP53—schizophrenia	2.54e-06	7.02e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOE—schizophrenia	2.52e-06	6.95e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOE—schizophrenia	2.5e-06	6.89e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOA1—schizophrenia	2.49e-06	6.87e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOA1—schizophrenia	2.47e-06	6.81e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—EP300—schizophrenia	2.43e-06	6.71e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TP53—schizophrenia	2.41e-06	6.64e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—AKT1—schizophrenia	2.38e-06	6.57e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—AKT1—schizophrenia	2.36e-06	6.51e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—AKT1—schizophrenia	2.27e-06	6.27e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—COMT—schizophrenia	2.19e-06	6.04e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTP1—schizophrenia	2.18e-06	6.01e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MAOA—schizophrenia	2.17e-06	6e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TP53—schizophrenia	2.17e-06	5.98e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—AKT1—schizophrenia	2.15e-06	5.92e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TP53—schizophrenia	2.12e-06	5.86e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—AKT1—schizophrenia	2.1e-06	5.79e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—EP300—schizophrenia	2.07e-06	5.7e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ABCB1—schizophrenia	2.06e-06	5.69e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—AKT1—schizophrenia	2.03e-06	5.61e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TP53—schizophrenia	2.01e-06	5.55e-06	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—AKT1—schizophrenia	2.01e-06	5.54e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTM1—schizophrenia	2e-06	5.52e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	2e-06	5.52e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—AKT1—schizophrenia	1.83e-06	5.05e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—AKT1—schizophrenia	1.79e-06	4.95e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MTHFR—schizophrenia	1.77e-06	4.88e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—EP300—schizophrenia	1.75e-06	4.82e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TP53—schizophrenia	1.74e-06	4.8e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—AKT1—schizophrenia	1.7e-06	4.7e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—AKT1—schizophrenia	1.7e-06	4.69e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOE—schizophrenia	1.65e-06	4.54e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOA1—schizophrenia	1.63e-06	4.49e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—EP300—schizophrenia	1.52e-06	4.2e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—AKT1—schizophrenia	1.47e-06	4.05e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—EP300—schizophrenia	1.44e-06	3.96e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—EP300—schizophrenia	1.42e-06	3.93e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—AKT1—schizophrenia	1.25e-06	3.44e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—AKT1—schizophrenia	1.06e-06	2.92e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—EP300—schizophrenia	9.39e-07	2.59e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—AKT1—schizophrenia	9.21e-07	2.54e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—AKT1—schizophrenia	8.68e-07	2.39e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—AKT1—schizophrenia	8.6e-07	2.37e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—AKT1—schizophrenia	5.67e-07	1.56e-06	CbGpPWpGaD
